V019-3294 Screening compound: 4-[6-(4-chlorobenzenesulfonyl)-4-(4-fluoro-3-methylphenoxy)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

V019-3294 Screening compound: 4-[6-(4-chlorobenzenesulfonyl)-4-(4-fluoro-3-methylphenoxy)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine
V019-3294 Screening compound: 4-[6-(4-chlorobenzenesulfonyl)-4-(4-fluoro-3-methylphenoxy)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-3294
4-[6-(4-chlorobenzenesulfonyl)-4-(4-fluoro-3-methylphenoxy)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-3294

Molecular Formula

C24H24ClFN4O4S (C24 H24 ClFN4 O4 S)

Compound Name

4-[6-(4-chlorobenzenesulfonyl)-4-(4-fluoro-3-methylphenoxy)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

IUPAC name

4-[6-(4-chlorobenzenesulfonyl)-4-(4-fluoro-3-methylphenoxy)-5H6H7H8H-pyrido[43-d]pyrimidin-2-yl]morpholine

SMILES

Cc(cc(cc1)Oc2c(CN(CC3)S(c(cc4)ccc4Cl)(=O)=O)c3nc(N3CCOCC3)n2)c1F

InChI

InChI=1S/C24H24ClFN4O4S/c1-16-14-18(4-7-21(16)26)34-23-20-15-30(35(31,32)19-5-2-17(25)3-6-19)9-8-22(20)27-24(28-23)29-10-12-33-13-11-29/h2-7,14H,8-13,15H2,1H3

InChI Key

WAEDXIGNAWAZCS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19979904

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

519

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.204

Distribution Coefficient, logD

5.204

Water Solubility, LogSw

-5.72

Polar Surface Area

69.477

Acid Dissociation Constant (pKa)

20.43

Base Dissociation Constant (pKb)

2.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

V019-3294 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V019-3294 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-3294?
Check Price and Availability of V019-3294, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-3294 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-3294
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-3294
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-3294 available by request